Sponsor Pipeline

Shenzhen Oculgen Biomedical Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07520318 This is a 96-week, Multicenter Study in Patients With Neovascular AMD That Evaluates… Adults With Neovascular Age-related Macular Degeneration Not Yet Recruiting
Get alerts when Shenzhen Oculgen Biomedical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free